METHYLENEDIOXYAMPHETAMINE - A SELECTIVE EFFECT ON CORTICAL CONTENT AND TURNOVER OF 5-HT

被引:2
作者
ROMANO, AG
DU, W
HARVEY, JA
机构
[1] Division of Behavioral Neurobiology, Department of Pharmacology, Medical College of Pennsylvania, Philadelphia, PA 19129
关键词
METHYLENEDIOXYAMPHETAMINE; SEROTONIN; CATECHOLAMINES; HALLUCINOGENS; RABBIT; FRONTAL CORTEX; HIPPOCAMPUS;
D O I
10.1016/0091-3057(94)90075-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study examined the effects of the hallucinogen, MDA, on brain content of monoamines and their metabolites in the rabbit. A single 1.8 mg/kg dose of MDA produced 30 to 64% increases in the 5-HT content of frontal cortex from 30 to 120 min after injection and a decrease in 5-HT turnover from 30 min to 8 h, but had no effect in hippocampus, caudate nucleus, or hypothalamus. A single 3.6 mg/kg dose of MDA also reduced the turnover of 5-HT in frontal cortex, but this was accompanied by a decrease in 5-HIAA with no increase in 5-HT. The 1.8 and 3.6 mg/kg doses of MDA had no significant or consistent effects on the contents of DA, DOPAC, HVA, and NE in any brain area examined. Chronic administration of MDA (3.6 mg/kg/day for 4 days) failed to produce any evidence of a neurotoxic action on 5-HT neurons. Higher doses could not be employed because the LD(50) of MDA was approximately 5 mg/kg. This study has demonstrated that behaviorally effective and nonneurotoxic doses of MDA produce increases in the content and decreases in turnover of 5-HT in frontal cortex that resemble those of other hallucinogens such as LSD and DOM.
引用
收藏
页码:599 / 607
页数:9
相关论文
共 32 条
[1]   HALLUCINOGENIC PHENYLETHYLAMINES - INTERACTIONS WITH SEROTONIN TURNOVER AND RECEPTORS [J].
ANDEN, NE ;
CORRODI, H ;
FUXE, K ;
MEEK, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 25 (02) :176-184
[2]  
[Anonymous], 1971, STAT PRINCIPLES EXPT
[3]  
BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911
[4]   CENTRALLY ACTIVE N-SUBSTITUTED ANALOGS OF 3,4-METHYLENEDIOXYPHENYLISOPROPYLAMINE (3,4-METHYLENEDIOXYAMPHETAMINE) [J].
BRAUN, U ;
SHULGIN, AT ;
BRAUN, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (02) :192-195
[5]   PSYCHOTOMIMETIC DRUGS AND BRAIN 5-HYDROXYTRYPTAMINE METABOLISM [J].
FREEDMAN, DX ;
GOTTLIEB, R ;
LOVELL, RA .
BIOCHEMICAL PHARMACOLOGY, 1970, 19 :1181-+
[6]  
FREEDMAN DX, 1961, J PHARMACOL EXP THER, V134, P160
[7]   MDA - A PSYCHOACTIVE AGENT WITH DUAL STIMULUS EFFECTS [J].
GLENNON, RA ;
YOUNG, R .
LIFE SCIENCES, 1984, 34 (04) :379-383
[8]   MDA - AN AGENT THAT PRODUCES STIMULUS EFFECTS SIMILAR TO THOSE OF 3,4-DMA, LSD AND COCAINE [J].
GLENNON, RA ;
YOUNG, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 99 (2-3) :249-250
[9]  
GLENNON RA, 1990, NEUROPSYCHOPHARMACOL, V3, P509
[10]   THE RAPHE NEURONAL SYSTEM AND SEROTONERGIC EFFECTS OF LSD [J].
HALARIS, AE ;
ROSENTHAL, M ;
DEMET, EM ;
FREEDMAN, DX .
NEUROPHARMACOLOGY, 1982, 21 (08) :811-816